About Us

Since its foundation in 2012, Plexense, Inc. has specialized

in the development and production of rapid and cost-effective

immunoassay platform for clinical, agricultural and biological testing.


Our proprietary technology, ACCEL ELISA®, provides up to

40X increase in sensitivity compared to conventional techniques.



Plexense, Inc. has been working as development and

collaboration partners with Mayo Clinic, the US Department

of Agriculture (USDA) – ARS, the Korea Center for Disease Control (KCDC) and the Korea Research Institute of Bioscience and Biotechnology (KRIBB) to develop

advanced early diagnostic kits utilizing its proprietary 

ACCEL ELISA® technology.

Plexense, Inc. headquartered in Korea with

primary R&D and production in Korea, as well.

It also has an affiliate company under the name 

Plexense BIO, Inc. in California and Florida, USA.



Head Office


#B-604, 670 Daewangpangyo-ro, Bundang-gu,

Seongnam-si, Gyeonggi-do,

Republic of Korea, 13494


R&D Center


#1-1301, 1302, 1303, 16-4 Dongbaekjoongang-ro

16 beongil, Giheung-gu, Yongin-si, Gyeonggi-do,

Republic of Korea, 17015


Plexense BIO, Inc.


4136E Commerce Way, Suite 300,

Sacramento, CA 95834 USA


Homepage  www.plexense.com

Republic of Korea  (+ 82) 70.4725.4681

USA  (+1) 916.280.0362


© 2020  Plexense, Inc. | info@plexense.com |Suite B604, Seongnam-si, Gyenggido,S.Korea13494